期刊文献+

七氟烷对乳腺癌BT549细胞侵袭、迁移及MMP-2、MMP-9表达的影响 被引量:2

The influence of sevoflurane on invasion,migration and expression of MMP-2,MMP-9 in breast cancer BT549 cells
下载PDF
导出
摘要 目的:探讨七氟烷对乳腺癌BT549细胞侵袭、迁移及基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶-9(MMP-9)表达的影响。方法:乳腺癌BT549细胞用七氟烷处理后,细胞划痕实验检测细胞迁移,Transwell小室检测细胞侵袭,Western blot检测MMP-2、MMP-9蛋白表达。结果:七氟烷处理后的BT549细胞迁移率由(36.45±3.21)%降低至(14.68±1.52)%,侵袭细胞数目由(136.58±13.36)个减少到(79.95±14.25)个,MMP-2水平由0.48±0.04减少为0.14±0.03,MMP-9水平由0.96±0.07减少为0.22±0.05,两组比较差异均具有统计学意义(P<0.05)。结论:七氟烷能够抑制乳腺癌BT549细胞迁移和侵袭,降低细胞中MMP-2、MMP-9表达水平。 Objective:To investigate the effects of sevoflurane on the invasion,migration and the expression of matrix metalloproteinase-2(MMP-2) and matrix metalloproteinase-9(MMP-9) of breast cancer BT549 cells.Methods:Breast cancer BT549 cells were treated with sevoflurane.Cell migration was detected by cell scratch test,Transwell chamber was used to detect cell invasion.Western blot was used to detect the expression of MMP-2 and MMP-9.Results:The cell migration rate of BT549 treated with sevoflurane decreased from(36.45±3.21)% to(14.68±1.52)%.The number of invasive cells decreased from(136.58±13.36) to(79.95±14.25).The levels of MMP-2 decreased from 0.48±0.04 to 0.14±0.03.The level of MMP-9 decreased from 0.96±0.07 to 0.22±0.05.There were significant differences between the two groups(P<0.05).Conclusion:Sevoflurane can inhibit the migration,invasion and reduce the expression of MMP-2 and MMP-9 of breast cancer BT549 cells.
作者 刘月芬 王承正 Liu Yuefen;Wang Chengzheng(Department of Oncology,Puyang Oilfield General Hospital,Henan Puyang 457001,China;Department of Breast Surgery,Affiliated Cancer Hospital of Zhengzhou University,Henan Zhengzhou 450008,China.)
出处 《现代肿瘤医学》 CAS 2019年第23期4162-4165,共4页 Journal of Modern Oncology
基金 河南省医学科技攻关计划普通项目(编号:201203156)
关键词 七氟烷 乳腺癌 MMP-2 MMP-9 侵袭 迁移 sevoflurane breast cancer MMP-2 MMP-9 invasion migration
  • 相关文献

参考文献3

二级参考文献24

  • 1Forouzanfar MH, Forem an KJ, Delossantos AM, et al. Breast and cer- vical cancer in 187 countries between 1980 and 2010: a systematic analysis [J]. Lancet, 2011,378(9801): 1461-1484.
  • 2Petit JY, Veronesi U, Rey P, et al. Nipple-sparing mastectomy: rick of nipple-areolar recurrence in a series of 576 ease [J]. Brest Cancer Res Treat, 2009, 114(1): 97-101.
  • 3Benediktsson K P, Perbeck I. Survival in breast cancer aftranipple -sparing subcutaneous mastectomy and immediate recon-struction with implants: a prospective trial with 13 years medianfollow-up in 216 patients [J]. Eur J Surg Oncol, 2008, 34 (2): 143-148.
  • 4Spear S L, WiBey S C, Feldman E D, et al. Nipple-sparing masteetomy for prophylactic and therapeutic indications [J]. Plast Reeonstr Surq, 2011,128(5): 1005 -1014.
  • 5Vlajcic z, Zie R, Stance S, et al. Nipple -areola complex preservation: predictive factors of neoplastie nipple -areola complex invasion [J]. Ann Plast Surg, 2005, 55(3): 240-244.
  • 6G. Patrick Maxwell, Toni Storm-Diekerson, Pat Whitworth, et al. Ad- vances in Nipple-Sparing Mastectumy: Ontological Safety and Inci- sion Selection [J]. Aesthetic Surgery Jouma, 2010, 131 (3): 310-319.
  • 7Mladcnov M, Chervenyakov P , Daskalova I, et al. Nip ple-sparing nlasteclomy (subeutaneal rnastectomy with pieserving of the arcolo- mammilar complex) like alternative of the modify radical mastectomy in selected cases [J]. Khirurgiia(Soliia), 2010(6): 23-27.
  • 8K rag DN, Anderson SJ, Julian TB, ct al. Sentincl-lyrnph-nodcrc sec- tion compared With conventional axillary-lyrnph-node dissection in clinically node-negative patients with breast cancer: overall survival findings fi'om the NSABP B -32 randomised phase 3 trial [J]. Lancet Oncol, 2010,11: 927-933.
  • 9Langer I, Gullcr U, Viebl CT, et al. Axillary lymph node dissection for sentinel lymph node mieremctastases may be safely omitted in early- stage breast cancer patients: long, term outcomes of a prospective study[J].Ann Sure Oncol, 2009, 16:3366 -3374.
  • 10Pemas S, Gil M, Benltez A, et al. Avoiding axillary treatment in sen- tinel lymph node micrometastases of breast cancer: a prospectivc analysis of axillary or distant recurrence[J]. Ann Sure Oncol, 2010, 17: 772-777.

共引文献109

同被引文献13

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部